Information updates

Telehealth Update

Following cessation of the temporary telehealth arrangements on 30 June 2022, the following permanent telehealth arrangements for medical specialists and consultant physicians in Australia apply from 1 July 2022:

  • A full range of services are catered for through 42 permanent telehealth video and 9 telephone items for specialists and consultant physicians.
  • Telehealth services for initial and subsequent attendances are permanently rebated through the MBS where delivered by videoconference, and minor attendances are permanently rebated when delivered by telephone or videoconference. These ongoing telehealth items took effect on 1 January 2022.
  • In line with this, MBS rebates for specialist services by phone will continue to be available, in the form of less complex or shorter subsequent consultations, and for consultations up to 45 minutes in duration for psychiatry. 
  • The arrangements reflect an accepted clinical position that face to face and video services support better patient care and outcomes, and should be the preferred form of consultation with patients, particularly for initial and complex consultations.
  • The Government has indicated it intends to defer to 1 October 2022, the implementation of the telephone specific 30/20 compliance rule which was to take effect on 1 July 2022.  

Additional information on the permanent telehealth items is available in the new Fact Sheet on the MBSOnline website MBS online - MBS Telehealth Services from 1 July 2022

If you have any questions in relation to this matter please direct these to the Medical Specialist Services Section via email at: This email address is being protected from spambots. You need JavaScript enabled to view it.

This news item was issued on 4 July 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.   

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia